|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||1.4400 - 1.5200|
|52 Week Range||0.8500 - 2.0400|
|Beta (3Y Monthly)||3.04|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Seaport Global Initiated Coverage on CGC, APHA, ACB, and HEXO(Continued from Prior Part)Supreme CannabisAmong cannabis stocks (MJ), Supreme Cannabis (SPRWF) has provided an impressive return of 47% YTD (year-to-date). The company outperformed
Seaport Global Initiated Coverage on CGC, APHA, ACB, and HEXO(Continued from Prior Part)OrganiGramLast month, OrganiGram (OGRMF) reported its first-quarter earnings for the quarter ending November 30. The earnings were received well and exceeded
Cannabis stocks were higher across the board on Tuesday, as investors digested the first earnings reports of the season and a first look at a pot banking bill that Democrats are hoping to pass in 2019.
Supreme Cannabis Co. Inc. said Tuesday it had a net loss of C$1.55 million ($1.17 million), or 1 cent a share, in its fiscal second quarter to Dec. 31, narrower than the C$2.03 million, or 1 cent a share, posted in the year-earlier period. Revenue rose to $7.72 million from $1.68 million. With only two analysts covering the stock, there are no reliable consensus estimates. The company said it made its first shipments of 7 Acres branded cannabis to six of Canada's provincially regulated adult-use channels in the quarter. It announced an international partnership with Khalifa Kush Enterprises to develop and launch cannabis products for the Canadian and international markets, excluding the U.S. U.S.-listed shares were not active premarket, but have fallen 14.7% in the last 12 months, while the S&P 500 has gained 2.0%.
TORONTO , Feb. 12, 2019 /CNW/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (FIRE.TO) (SPRWF) (53S1.F), announced the release of its financial and operating results for the three and six months ended December 31, 2018 . Q2 2019 revenue for the Company was $7.72 million , a 359% increase from Q2 2018 ( $1.68 million ) and a 50% increase from Q1 2019 ( $5.14 million ). Q2 2019 net comprehensive loss for the Company was $1.55 million , compared to a net loss of $2.03 million in Q2 2018 and a net loss of $5.39 million in Q1 2019.
CORAL GABLES, FL / ACCESSWIRE / February 11, 2019 / The marijuana stock market has occupied media headlines over the course of the past couple of years, during the course of which top players in the industry saw huge boosts in investor interest. In recent news, lawmakers have pushed for the passing of legislation in favor of legalizing marijuana, and as a result, the marijuana stock market has responded well. ParcelPal Technology Inc (PTNYF) (PKG), along with other companies in the industry, is taking advantage of the fact that we are seeing a steady increase in consumer approval of cannabis and its myriad of uses.
TORONTO , Feb. 8, 2019 /CNW/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (FIRE.TO) (SPRWF) (53S1.F), is pleased to announce it has received approval from The Depository Trust Company ("DTC") of New York to make the Company's shares DTC eligible. DTC is a subsidiary of the Depository Trust & Clearing Corporation, a U.S. company that manages the electronic clearing and settlement of publicly traded companies.
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot reporting on the CBD market As it grows, branding becomes essential to companies hoping to stand out. According to Brightfield Group analysts, the CBD market is expected to hit $22 billion by 2022, overtaking the cannabis market with $20 billion by 2020. This is good news for most companies in the sector, but it also adds to market saturation, which means brand awareness may be the only way to stay ahead of the pack.
As we see an increase in agricultural technology being used to increase the yield, and quality, of cannabis products, companies across the space will have greater access to inventory to distribute their products. Considering the fact that legal marijuana is becoming a reality in a large portion of the United States, Canada, and abroad, investors that have historically written off cannabis companies, are now flocking in droves with excitement. Nabis Holdings (INNPF) (NAB), Emerald Health Therapeutics Inc (EMHTF) (EMH.V), Green Growth Brands Inc (GGBXF), and The Supreme Cannabis Company (SPRWF) are four cannabis companies worth keeping on your radar on Thursday.
Supreme Cannabis' wholly owned subsidiary, 7ACRES, has agreed to supply cannabis to retailers in the provinces of New Brunswick and Saskatchewan. TORONTO, Feb. 7, 2019 /PRNewswire/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (FIRE.V) (SPRWF) (53S1.F) announced that the Company's wholly owned subsidiary, 7ACRES, has entered into a supply agreement with the New Brunswick Liquor Corporation to supply recreational cannabis to its retail stores and has been registered as a supplier in the province of Saskatchewan.
TORONTO , Feb. 5, 2019 /CNW/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (FIRE.TO) (SPRWF) (53S1.F) today announced that it will be providing its second quarter financial results for the three months ended December 31, 2018 before markets open on February 12, 2019 . The Supreme Cannabis Company (FIRE.TO) (SPRWF) (53S1.F) is a Canadian publicly traded company committed to providing premium brands and products that proudly reflect its consumers, people and uniquely innovative culture.
CORAL GABLES, FL / ACCESSWIRE / February 4, 2019 / The marijuana stock market has continued to demonstrate its strength despite the fact that, at times, conversation surrounding cannabis can become less than beneficial. The cannabis industry as a whole is scheduled to be worth as much as $31 billion by the year 2022, which means that there is a large amount of room left still to grow. Nabis Holdings (INNPF) (NAB), Green Growth Brands Inc (GGBXF) (GGB.CN), Khiron Life Sciences Corp (KHRNF), and The Supreme Cannabis Company Inc (SPRWF) are four cannabis companies working towards improving the quality of life for their consumers.
Canopy Growth's Bruce Linton Talks Next Steps for the Industry(Continued from Prior Part)A commodityWhen a product becomes a commodity, it means that the product offered has no significantly distinguishable characteristics from one producer to the
Editor's Note: This story was previously published in November, 2018. It has since been updated and republished. After the most recent midterm elections it was clear that Americans preferred legalization over the continued prohibition of pot, which should bolster the case for the top marijuana penny stocks. When residents in California voted for full recreational weed, it boded well not just for marijuana penny stocks, but for electoral momentum in other states and the midterms emphatically proved this point. InvestorPlace - Stock Market News, Stock Advice & Trading Tips In conservative Utah and Missouri, voters approved medical cannabis. But Michigan stood above the rest, becoming the tenth state to legalize recreational marijuana. Significantly, it's also the first Midwestern state to approve such an initiative. * 7 S&P 500 Stocks to Buy That Tore Up Earnings Previously embattled marijuana stocks like Cronos Group (NASDAQ:CRON), Tilray (NASDAQ:TLRY), and Canopy Growth (NYSE:CGC) received a much-needed boost in the markets and really have capitalized on it. Recent booms in these stocks make it easy to see why. Not only does legal marijuana open doors to a previously inaccessible sector, it has proven economic benefits. The commonly-cited case study is Colorado. In 2015, one year after green lighting cannabis businesses, the botanical industry nearly hit $1 billion in revenue. In 2016, it breached the threshold, and growth remains strong. Considering that so many states suffer from budget shortfalls, a little green could go a long way. Under this backdrop, gambling on top marijuana penny stocks is more compelling than jumping on any other speculative venture. While risks abound, these four sector players offer considerable upside possibilities. Source: MarihuanayMedicina via Flickr ### Auxly Cannabis Group (CBWTF) A common difficulty in forecasting future price movements for top marijuana penny stocks is separating hype from reality. While almost every sector player advertises significant upside potential, most undercapitalized firms fail to deliver the goods. I had high hopes for Auxly Cannabis (OTCMKTS:CBWTF) last year due to its unique business structure. Auxly earned bragging rights for becoming the first cannabis streaming company. Energy and mining companies typically deploy the streaming model to gain full access to an industry's supply chain without incurring unnecessary risk. In theory, streaming is the way to go for marijuana-related organizations. Even with Canada's legalization initiative and U.S. electoral momentum, several legal and administrative hurdles exist. Streaming facilitates exposure to a lucrative industry, but with "stop gaps" should things go awry. Unfortunately, the markets have not been kind to Auxly stock. Since its January opener, shares have lost more than half their equity value. Nevertheless, I'm still hopeful that Auxly can pull it together. Legal marijuana really still is in its infancy so we should expect growing pains. Moreover, CBWTF has settled into its long-range support line around 70 cents. It's a hefty risk, but a worthwhile one with gambling money. Source: Shutterstock ### MPX Bioceutical (MPXEF) A common stereotype about legal-cannabis advocates is that they have ulterior motives for their product evangelism. Although that could be the case, one thing is undeniable: many, if not most top marijuana penny stocks focus on botany's medicinal aspect. This is especially true for MPX Bioceutical (OTCMKTS:MPXEF). MPX operates three brands under its corporate umbrella: Salus BioPharma, Health for Life, and its namesake MPX. The former two divisions specialize in medical-grade cannabis, while the latter caters to the green lifestyle. Salus is particularly intriguing as it represents a joint venture with Israeli pharmaceutical Panaxia to develop proprietary, smokeless cannabis products. Another compelling driver for MPXEF stock is its technical momentum, as it lacks the extreme volatility seen in other sector-related speculative companies. * 7 Stocks With Too Much Riding On China That's not to say you should jump on MPXEF stock without worries. The company isn't what you would consider fundamentally sound. Still, with relatively-stable market performance and an impressive growth rate, speculators will want to keep close tabs on MPX. Source: Shutterstock ### Supreme Cannabis Company (SPRWF) When Canada became the first G7 nation to approve recreational weed in October 2018, it actually forged the path forward for marijuana startups. As a result, the lion's share of marijuana penny stocks are based in Canada. A prime example is Supreme Cannabis Company (OTCMKTS:SPRWF). Supreme Cannabis, whose 7ACRES brand of medical-grade cannabis started life as a father seeking alternative therapies for his daughter. Eventually, 7ACRES grew to become a gold-standard cannabis facility, offering distinct, high-quality strains. What makes SPRWF stand out compared to other top marijuana penny stocks is that management is focused on a business-to-business (B2B) strategy. This enables the company to fine-tune its craft, rather than dilute its effectiveness through disparate supply-chain segments. Last year the markets acknowledged Supreme Cannabis' potential, but the ride was anything but smooth. SPRWF stock doubled in value between mid-August through September-end. However, it crashed back down to earth by mid-October, 2018. Since then, SPRWF stock has managed to hold onto long-term support above $1. It's a high-risk, high-reward venture, but a very tempting one. Source: Shutterstock ### Cannabis Science (CBIS) Cannabis Science (OTCMKTS:CBIS) is easily one of the most speculative among top marijuana penny stocks. Immediately, you can tell that through either its ridiculously-low share price, or its sub-$100 million market capitalization. Another giveaway is Cannabis Science's bold declaration to provide innovative therapies for unmet medical needs, including cancer. As the old saying goes, extraordinary claims require extraordinary evidence. But this is also where CBIS stock becomes interesting. Management claims that cannabis use dates back thousands of years, making it one of the most tried-and-true medicines. Plus, traditional pharmaceutical companies have become more a marketing machine than a therapy provider. Therefore, the medical-cannabis industry deserves at least some credibility. * 10 F-Rated Stocks That Could Break Your Portfolio That's the good news for CBIS stock. The not so great news is that shares continue to struggle. Conservative investors should probably stay away from Cannabis Science and marijuana penny stocks in general. But the encouraging note is that CBIS stock has stabilized since before the beginning of the year. That's no guarantee of a turnaround, but any positive movements are likely to be explosive. As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 S&P 500 Stocks to Buy That Tore Up Earnings * 10 Cold Weather Stocks to Heat Up Your Returns * The 7 Best Penny Stocks to Buy Compare Brokers The post 4 Top Marijuana Penny Stocks to Take Seriously in 2019 appeared first on InvestorPlace.
Following the recent passing of the U.S. Farm Bill, companies in the cannabis industry received the boost they needed from lawmakers to nudge consumers in the right direction, resulting in an increase in favorable public opinion. As we close out the month of January, Leafbuyer Technologies Inc (LBUY), The Supreme Cannabis Company Inc (SPRWF), InMed Pharmaceuticals Inc (IMLFF), and Aphria Inc (APHA) (APHA) are 4 pot stocks looking to set the pace on Friday. Leafbuyer Technologies Inc (LBUY) is one of the leading online resources for those in the cannabis industry.
Why Aphria Rose 13% on January 31(Continued from Prior Part)Premium vanishedGreen Growth touted a 45% premium for Aphria shares when it made the offer in December. The offer valued Aphria (APHA) at 11 Canadian dollars. Since then, Aphria has
TORONTO , Jan. 31, 2019 /CNW/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (FIRE.V) (SPRWF) (53S1.F) announced today that its listed securities are expected to commence trading on the Toronto Stock Echange (the "TSX") on February 4, 2019 . At that time, Supreme Cannabis' common shares and 6.0% senior unsecured convertible debentures due 2021 will be voluntarily delisted from the TSX Venture Exchange and will commence trading on the TSX under the symbols "FIRE" and "FIRE.DB", respectively. On February 4, 2019 , Supreme Cannabis will also participate in the market open ceremony.
7ACRES receives Health Canada approval for approximately 30,000 sqft of additional production space. Licensed space at 7ACRES increases to 120,000 sqft and target annual production capacity is expected to increase to approximately 17,500kg. 7ACRES also received Health Canada approval for its plant micropropagation space.
Cannabis Players' Valuations: Which Stocks Look Cheap in January?(Continued from Prior Part)The remaining five cannabis stocks In the previous article, we discussed the EV-to-sales (enterprise value-to-sales) multiples of four cannabis stocks and